Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein

Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein

The potential of immune-evasive mutation accumulation in the SARS-CoV-2 virus has led to its rapid spread, causing over 600 million confirmed cases and more than 6.5 million confirmed deaths. The huge demand for the rapid development and deployment of low-cost and effective vaccines against emerging...

Full description

Bibliographic Details
Main Authors: Dmitri Dormeshkin, Mikalai Katsin, Maria Stegantseva, Sergey Golenchenko, Michail Shapira, Simon Dubovik, Dzmitry Lutskovich, Anton Kavaleuski, Alexander Meleshko
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Vaccines
Subjects:
COVID-19
SARS-CoV-2
DNA vaccine
receptor binding domain
Online Access:https://www.mdpi.com/2076-393X/11/6/1014

Internet

https://www.mdpi.com/2076-393X/11/6/1014

Similar Items